Benitec Biopharma Inc. - Common Stock (BNTC)

Historical Holders from Q3 2023 to Q3 2025

Symbol
BNTC on Nasdaq
Type / Class
Equity / Common Stock
Shares outstanding
33,862,222
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares, excl. options
23,155,290
Holdings value
$324,725,424
% of all portfolios
0%
Number of holders
54
Number of buys
31
Number of sells
-16
Average buys %
+0%
Average sells %
-0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Benitec Biopharma Inc. - Common Stock (BNTC)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
SUVRETTA CAPITAL MANAGEMENT, LLC 44.1% -11.6% $249,200,088 +$30,000,153 17,761,945 +13.7% SUVRETTA CAPITAL MANAGEMENT, LLC 07 Nov 2025
FRANKLIN RESOURCES INC 14.9% -8.8% $58,140,839 -$3,803,435 4,144,037 -6.1% Franklin Resources, Inc. 30 Sep 2025
JANUS HENDERSON GROUP PLC 9.99% -11.9% $44,484,293 -$292,158,468 3,382,836 -86.8% JANUS HENDERSON GROUP PLC 28 Nov 2025
RA CAPITAL MANAGEMENT, L.P. 5.5% $24,327,500 1,850,000 RA Capital Management, L.P. 07 Nov 2025
HBM Healthcare Investments (Cayman) Ltd. 4.5% $14,156,282 1,041,669 HBM Healthcare Investments (Cayman) Ltd. 31 Dec 2024
Nantahala Capital Management, LLC 4.39% -52.6% $14,111,462 1,038,371 0% Nantahala Capital Management, LLC 31 Mar 2025

Institutional Holders of Benitec Biopharma Inc. - Common Stock (BNTC)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q3 23,155,290 $324,725,424 +$6,865,160 $14.03 54
2025 Q2 22,685,530 $265,306,276 +$16,737,178 $11.7 56
2025 Q1 21,243,183 $277,395,506 +$28,289,371 $13.01 37
2024 Q4 18,997,897 $240,166,135 +$64,576,294 $12.63 30
2024 Q3 13,715,023 $126,792,177 +$73,385,856 $9.19 25
2024 Q2 5,729,459 $39,940,820 +$31,087,038 $6.99 18
2024 Q1 1,270,837 $6,576,960 +$379,920 $5.25 13
2023 Q4 1,197,615 $3,880,452 -$214,565 $3.23 13
2023 Q3 1,267,947 $3,838,114 +$3,838,114 $3.02 11